This paper analyses access to medicines in India and Brazil after the entry into force of the TRIPS Agreements, covering the different response of both countries as to its implementation. Such International Treaty has introduced deep innovations in the international framework for patents that may create a barrier to the access of more affordable medicines. The paper covers emblematic case law from both countries and concludes with an assessment of the different implementation strategies.
|Number of pages||12|
|Journal||European Intellectual Property Review: A Monthly Review: A Journal concerning the Management of Technology, Copyrights and Trade Names|
|Publication status||Published - 2014|
- Access to medicines; Brazil; Comparative law; Compulsory licensing; India; Pharmaceuticals; TRIPs